Stock Screener App

무료 - Play StoreApp Store

설치하다 설치하다

Dow:

Nasdaq:

S&P 500:

DGX

$251.820.43%-1.10

Quest Diagnostics Inc (DGX)

Date: O: H: L: C: Vol:

Quest Diagnostics Inc 주식(DGX)의 최신 뉴스

Quest Diagnostics class action alleges data breach exposed patient medical records - Claim Depot

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch

Quest Diagnostics faces multiple class action lawsuits over lab data breach - Top Class Actions

Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235 - marketscreener.com

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends? - Zacks Investment Research

Quest Diagnostics data breach hits patient records in lab system - Top Class Actions

Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's - Seeking Alpha

Form 144 QUEST DIAGNOSTICS INC For: 26 October By Investing.com - Investing.com Canada

Form 144 QUEST DIAGNOSTICS INC For: 26 October By Investing.com - Investing.com UK

A director proposes selling 1,203 shares of Quest Diagnostics (NYSE: DGX). - Stock Titan

Quest Diagnostics Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Unauthorized Access to Patient Records - Morningstar

Quest Diagnostics 3Q 2026: Revenue $3.1B, Net income $312M, EPS $2.78— 10-Q Summary - TradingView

Quest Diagnostics investigating data breach involving patient records - Tri-State Alert

Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach - TechCrunch

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term - Zacks Investment Research

Quest Diagnostics reports unauthorized access to lab system, says patient information may have been compromised - WRNJ Radio

Quest Diagnostics Data Breach Exposed ‘Certain Patient Records’ - SecurityWeek

Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $254.5, Implies 7% Upside - TradingView

Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance

Quest Diagnostics confirms patient information accessed in cyberattack, systems temporarily shut down - Fox Business

Quest Diagnostics’ test results system breached in yet another medtech cyberattack - RamaOnHealthcare

Quest Diagnostics Inc (DGX) (Q3 2026) Earnings Call Highlights: Double-Digit Revenue Growth, ... - Yahoo Finance

Quest Diagnostics hit by cyberattack - MedTech Dive

Quest Diagnostics: 3 Key Takeaways for Long-Term Investors - Yahoo Finance

What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call - TradingView

Quest Diagnostics Incorporated Q3 2026 Earnings Call Summary - Yahoo Finance

DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market - Zacks Investment Research

Quest Diagnostics reports cyber breach affecting ‘certain patient records’ - KJCT

Quest Diagnostics boosts 2026 revenue, EPS guidance - TradingView

Laboratory operator Quest reports cyber breach affecting patient records - Reuters

Quest Diagnostics reports cyber breach affecting ‘certain patient records’ - Fox 59

Quest Diagnostics Pushing for PAMA Reform as End of Year Approaches - GenomeWeb

Quest Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView

Is Quest Diagnostics Inc (DGX) Overvalued After Q3 Earnings Beat - GuruFocus

Quest Diagnostics falls despite beat and raised guidance - Investing.com

Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates - Zacks Investment Research

Quest Diagnostics: Q3 Earnings Snapshot - Yahoo Finance

Quest Diagnostics: Q3 Earnings Snapshot - WUSA9

Quest Diagnostics (DGX): Is Rapid Test Growth Translating Into Better Customer Economics? - Yahoo Finance

Waters, Quest Diagnostics Collaborate to Expand Access to At-Home HPV Screening for Cervical Cancer - marketscreener.com

Quest Diagnostics Inc expected to post earnings of $2.86 a share - Earnings Preview - TradingView

Quest Diagnostics, Waters plan at-home HPV access in 2027 | DGX Stock News - Stock Titan

A new at-home HPV test kit is going national through Quest Diagnostics - Fast Company

Quest Diagnostics Slides as Investors Weigh Medicare Lab Payment Cut Risk - Quiver Quantitative

UBS Raises Quest Diagnostics Price Target to $250 From $245, Maintains Neutral Rating - marketscreener.com

Current guidelines may miss half of people with a hormone disorder tied to high blood pressure. - Stock Titan

DGX4807226 Bond Profile: Coupon and Redemption - TradingView

Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch

Quest Diagnostics Incorporated (DGX) Options Chain - Yahoo Finance - Yahoo! Finance Canada

Quest Diagnostics Incorporated (DGX) Options Chain - Yahoo Finance - Yahoo! Finance Canada

DGX와(과) 유사한 종목

MTD$1,674.812.55%

ILMN$235.9918.64%

MEDP$652.013.77%

RVTY$157.005.30%